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TOBACCO USE IN THE THIRD-TRIMESTER OF PREGNANCY AND ITS 1	
RELATIONSHIP TO BIRTH WEIGHT. 2	
A prospective study in Spain. 3	
 4	
INTRODUCTION 5	
Optimal foetal growth is dependant on a variety of physiological and pathological determinants1. 6	
Amongst the physiological factors, pre-gestational body mass index (BMI) is directly related to birth 7	
weight, with higher BMI associated with higher birth weight2. On the contrary, the misuse of toxic 8	
substances during pregnancy, including tobacco, can lead to foetal growth retardation and low birth 9	
weight3,4. Nicotine reduces the blood flow to the placenta, whilst carbon monoxide present in smoke 10	
reduces oxygenation of the fetus5.  11	
 12	
Different authors have analysed tobacco use during pregnancy using different methods including self-13	
reported questionnaires, measurements of nicotine concentration in urine or expired carbon 14	
monoxide6-8. In Europe, the prevalence of tobacco use during pregnancy is approximately 20%9. In 15	
Spain, figures are higher and around 30–43% of expectant mothers are smokers at the start of their 16	
pregnancy6. Although about 40% of them quit in the first trimester10, about 13–25% continue smoking 17	
up to delivery11. Spanish studies, however, are affected by methodological weaknesses. For example, 18	
the majority of studies assessed tobacco use through self-reported instruments, which may facilitate 19	
socially desirable responses and thus underestimate smoking status by 11–26%6,10.  20	
 21	
However, the combined effect of BMI and tobacco on birth weight remains unclear12 and few studies 22	
on tobacco prevalence have examined the effect of quitting smoking in the third-trimester of 23	
pregnancy and birth weight. Some authors have suggested that early cessation of smoking in 24	
pregnancy has a greater impact on birth weight improvement13,14 with a relatively small impact if 25	
quitting takes place during the third-trimester of pregnancy15. However, other researchers have 26	
claimed that third-trimester maternal cigarette consumption had the strongest association with birth 27	
weight, regardless of pre-pregnancy consumption levels16.Our study evaluated the association of 28	
prenatal exposure to maternal smoking with birth weight in different stages of pregnancy. 29	
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Additionally, we aimed to identify the trimester of pregnancy in which tobacco use produced the 30	
greatest reduction in neonatal birth weight. 31	
 32	
SUBJECTS AND METHODS 33	
Design: Prospective observational study. Participating expectant mothers were classified into two 34	
groups according to their use of tobacco during gestation. A sample of 159 women was obtained from 35	
April 2011 to March 2012.  36	
A two-stage sampling approach was used. In the first stage, we selected health centers in Carlet and 37	
Benimodo (Spain) from all primary care centers of La Ribera health district using simple random 38	
probability sampling (probability= 2/13). In the second stage, we selected pregnant women using a 39	
similar probability sampling with systematic monitoring of the number of pregnancies per year on 40	
each health center (N'). The ratio’s value (k) for the calculated sample size (n) was 2 (k = N'/ n). We 41	
estimated that for 180 pregnant women per year attending the health centers, a minimum sample of 42	
123 women was required (95% confidence interval (95% CI), 5% precision error). The attending 43	
midwives recruited the women at clinic and obtained their informed consent to participate. Overall, 44	
one of every two pregnant women was selected until the required sample size was obtained. 45	
The inclusion criteria were: a maternal age of 18-36 years, first prenatal visit between 5-12 weeks of 46	
gestation, and single foetus with no malformations. Exclusion criteria included: patient declined to 47	
participate in the study, language barrier, and expectant mothers with pathologies that significantly 48	
modified foetal growth, such as pre-gestational diabetes, essential hypertension prior to pregnancy, 49	
maternal infection or other chronic maternal pathologies.  50	
Ethics: The Committee of Ethics and Research of the University Hospital of La Ribera (UHLR) 51	
approved the study proposal in January 2011 (#11-415). Written informed consent was obtained from 52	
all women. The participants were free to decline their participation and withdraw from the research at 53	
any time. 54	
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Study variables: The questionnaire was purposely designed with agreement from the research team. 55	
Birth weight was considered the dependent variable, and was recorded in the delivery room following 56	
the clamping and separation of the umbilical cord, using a digital scale (SECA®, Vogel & Halke 57	
GmbH & Co, Hamburg, Germany), to an accuracy of 10 g. 58	
The independent variables included socio-demographic characteristics (maternal age, country of 59	
origin, marital status, educational level, occupational state), anthropometric measurements (pre-60	
gestational BMI, as calculated from self-reported body weight at 2–3 months prior to pregnancy and 61	
recorded at the first prenatal visit; absolute gestational weight gain; and difference between final 62	
weight on the day of delivery and pre-gestational weight), and obstetric-neonatal features (newborn 63	
gender and gestational age at birth expressed in days of gestation from the end of the mother’s last 64	
menstrual cycle). Women selected for inclusion in our study provided an estimate of their pre-65	
pregnancy day cigarette consumption. Self-reported average tobacco consumption was used to 66	
estimate pre-gestational tobacco misuse. Equally, women were asked to report the mean number of 67	
cigarettes consumed per day in the 7 days prior to the enrolment in the study, and again for each 68	
trimester on appointment with the midwife. 69	
Data collection also included the frequency of smoking cessation attempts and relapses during 70	
pregnancy and for a period of 30 days postpartum. 71	
Statistical analysis: An analysis of the dependent variables was carried out for each of the categories 72	
of pre-gestational BMI, using descriptive methods. Afterwards, the normality of the distribution of 73	
continuous variables was examined using the Kolmogorov-Smirnov test. Statistical significance was 74	
set at the 0.05 level. Bivariate correlation analyses using Pearson correlation coefficient were initially 75	
used to explore factors associated with neonatal birth. The comparison of multiple averages was 76	
carried out using analysis of variance tests (ANOVA), after assessment of the homogeneity and 77	
normality of the data with the Levene test. The magnitude of the effect of first-hand exposure to 78	
tobacco on categorised birth weight was estimated using multiple logistic regression, with birth weight 79	
(<3000g or >3000g) as the outcome measure and adjusted for pre-gestational maternal BMI (WHO 80	
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categories: underweight (UW) <18.5 Kg/m2, normal weight (NW) 18.5-24.9 Kg/m2, overweight (OW) 81	
25.0-29.9 Kg/m2, obese (OB) >30 Kg/m2)17 as explanatory variable. Additional explanatory variables 82	
included gestational age at birth (days).  83	
To analyse the relationship between birth weight (dependent variable) and tobacco use by the 84	
expectant mother (independent variable), an adjusted multiple linear regression model was applied 85	
using a stepwise method for variables shown to have an effect on birth weight. Smoking indicators 86	
examined included the number of cigarettes consumed per day before pregnancy, at the time of 87	
registration into the study (first trimester), and in the second and third trimester. Partial correlation 88	
coefficients represent the strength of the linear relationship between each independent variable and 89	
birth weight, after controlling for other predictors in the regression model. The data was analysed 90	
using SPSS Statistics version 22.  91	
RESULTS 92	
Out of a total of 159 expectant mothers initially included in the study, we excluded 22 cases (10 cases 93	
of spontaneous miscarriage in the first trimester, 1 case of foetal malformation in the second trimester, 94	
2 cases of loss to follow-up during the pregnancy, and 9 cases of gestational diabetes). Therefore, the 95	
final sample included 137 expectant mothers. 96	
Table 1 provides a detailed description of maternal and neonatal characteristics. Smokers were 30-34 97	
years old, less educated, married, employees and more frequently within normal weight than non-98	
smokers at each corresponding point during gestation. The neonatal birth weight of smoking mothers 99	
was 235g lower than non-smokers (p= 0.006).  100	
Table 2 presents tobacco statuses. Regarding pre-pregnancy tobacco use, 64.2% (88) did not smoke, 101	
35.8% (49) did, and 0.8% (1) quit prior to becoming pregnant. At the beginning of pregnancy, the 102	
proportion of smokers was 35%, of whom 14.6% were underweight, 68.8% were normal weight and 103	
26.7% were overweight. None of the mothers smoking prior to pregnancy were obese. In terms of 104	
smoking cessation during pregnancy, cessation rates increased progressively during the three 105	
	 5	
trimesters (8%, 13.1% y 13.9% respectively). We did not find any expectant mothers who relapsed 106	
during pregnancy or during 30 days of post-partum. Underweight smokers accounted for the largest 107	
proportion of those who stopped smoking (44.5%) when compared to women who either had normal 108	
weight (12.6%) or were overweight (10%). Additionally, underweight smokers achieved a greater 109	
reduction in the average number of cigarettes smoked compared to women who had normal weight 110	
(4.3 fewer daily cigarettes compared to 1.0). Overweight smokers, on the contrary, had increased their 111	
daily average consumption by 3.1 cigarettes by the end of their pregnancies.  112	
The results of the bivariate analysis on tobacco status and birth weight for different trimesters of 113	
gestation, according to categorised pre-gestational maternal BMI are displayed in Table 3. Maternal 114	
smoking was associated with birth weight only at NW pre-gestational BMI. Of the smoking indicators 115	
examined, cigarette consumption was significantly and negatively correlated with birth weight before 116	
pregnancy (R= -0.243, p= 0.018), as well as the second (R= -0.276, p= 0.007) and third trimester (R= -117	
0.304, p= 0.003). Birth weight in newborns from non-smoking mothers was significantly higher when 118	
compared with smoking participants (3297.8g [95% CI: 3187.6–3408.0] compared to 3070.1g [95% 119	
CI: 2910.4–3229.8], p= 0.018). Likewise, expectant mothers who did not smoke in the second and 120	
third trimesters had babies with higher birth weight than mothers who were smokers during those 121	
periods (3284.3g [95% CI: 3179.8–3388.9] vs 2990.6g [95% CI: 2816.7–3164.5] for the second 122	
trimester and 3289.0g [3185.5–3392.6] compared to 2960.2g [95% CI: 2789.8–3130.6] for the third), 123	
with statistically significant differences (p= 0.007 and p= 0.003, respectively). 124	
Table 4 describes the risk of having a newborn with a weight below 3000g, according to smoking 125	
behaviour during pregnancy, and adjusted for pre-gestational maternal BMI and gestational age at 126	
birth. Expectant mothers exposed to tobacco during the third trimester were at greater risk of having a 127	
lower neonatal weight than their non-smoking counterparts (OR: 5.94 [CI 95%: 1.94-18.16]). 128	
 129	
The results of the multiple regression analyses (Table 5 and Figure 1) suggest that of the smoking 130	
variables examined, maternal third trimester cigarette consumption was the strongest predictor of birth 131	
weight after adjusting for gestational age and pre-gestational maternal BMI (partial R= -0.253, p= 132	
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0.003). For each additional cigarette per day smoked in the third-trimester, there was an estimated 133	
reduction in birth weight of 32g (CI 95%: -53.08, -11.04). Additional direct independent contributors 134	
to birth weight after adjusting for gestational age (partial R= 0.404, p< 0.001) included maternal BMI 135	
(partial R= 0.281, p= 0.006). The final model included 3 variables and explained 27% of the 136	
variability in newborn birth weight. 137	
 138	
DISCUSSION 139	
Our prospective observational study included 137 expectant mothers in Spain, who were classified 140	
into groups according to their gestational tobacco use. In our results, pre-gestational maternal BMI is 141	
positively related to birth weight, independently of all other parameters examined, and in agreement 142	
with other studies2,3,18. In the Spanish health care system, midwives are the main point of contact for 143	
women during pregnancy. National guidelines indicate that midwives should ask about women’s 144	
smoking status at the first antenatal appointment (usually between 8-12 weeks), and provide smoking 145	
cessation advice and referral if warranted. However, there is still a paucity of data regarding the 146	
impact of smoking cessation advice on smoking status. 147	
 148	
 The proportion of smokers decreased progressively from the first to the third trimester, which is also 149	
consistent with previous studies6,7,10,11,13,19. In our study, we observed statistically significant 150	
differences between cigarette consumption and maternal age, educational level and occupational 151	
state20. 152	
 153	
Our data suggest that, taking into consideration already known factors that influence on birth weight, a 154	
linear relation persists between self-reported consumption of cigarettes in the third trimester and 155	
neonatal birth weight, as previously reported17. However, other studies have postulated safe levels of 156	
tobacco consumption15,21,22. The observable effect of maternal smoking later in pregnancy suggests 157	
that every additional cigarette consumed per day in the third-trimester results in a reduction of 158	
approximately 32g in the birth weight of the newborn. Such effect appears to be greater than the 159	
previously reported by Bernstein et al.16, Mathai et al.23 or England et al.15 who noted between 12g-160	
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27g. Overall, our results propose a total weight reduction of 137.6g (32g/cigarette x 4.3 161	
cigarettes/day), within the range determined by other authors20,24,25 reporting a weight fall between 162	
114-170g among smokers. The greater per-cigarette influence on birth weight in our data can be 163	
explained by the continuous linear relationship we observed. Thus, we disagree with the notion of a 164	
minimum secure level on cigarette consumption rather than a continuous effect.  165	
 166	
A valid estimation of the risks associated with tobacco exposure would depend on accurate 167	
measurements. However, some individuals may be more reluctant than others to disclose their 168	
smoking status and exposure to tobacco. This can be particularly true for pregnant women, for whom 169	
smoking may be regarded as socially unacceptable. Thus, estimates based on self-reported information 170	
are likely to underestimate the real proportion of tobacco use. Exposure to tobacco can be analyzed by 171	
measuring smoke components in the air, self-reported indicators of exposure through interviews or 172	
measuring smoke components concentrations with biomarkers26. The first approach is suboptimal as 173	
monitors can only be used for short periods of time, which are unlikely to be reflective of overall 174	
exposure. In terms of self-reported smoking behaviors, a recent meta-analysis27 suggested that in most 175	
studies it could be an acceptable methodology for estimating tobacco consumption, if validated with 176	
biochemical measurements. However, the authors excluded studies which included pregnant women. 177	
Other authors have concluded that validation with biomarkers should also be considered in studies 178	
with students and intervention studies28,29. Despite these advantages, self-reported questionnaires 179	
present various concerns related to their validity as tools for data collection, a lack of validation and 180	
standardization as well as misclassification of exposure among the most serious drawbacks. These 181	
may originate from participants’ failure to accurately recall exposure, lack of knowledge, intentional 182	
false reporting, biased recall, or memory failure28. Bias may be more common whenever social 183	
desirability is greater11. Furthermore, the quantity of inhaled and absorbed smoking products varies 184	
with the manner of smoking, which may be difficult to express and quantify in a questionnaire25. 185	
Underreporting was found in 4%-12% of pregnant women who demonstrated values inconsistent with 186	
their self-report 26. 187	
 188	
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Other investigators have identified a poor correlation of self-reported maternal cigarette consumption 189	
with biomarkers like urinary cotinine. They have reported an inversely proportional relationship of 190	
urinary nicotine to birth weight15,30.  191	
 192	
Some methodological considerations should be noted with regard to our study. First, our results rely 193	
on the validity of responses to the self-reported questionnaire. Consequently, the prevalence we 194	
observed may effectively be an underestimation of the true prevalence, due to the potential for socially 195	
desirable responses offered by our participants. The factors most closely related to concealing an 196	
individual’s smoking status have to do with the timing and the quantity of tobacco consumed 9,12,32.  197	
We acknowledge that in optimal circumstances, midwives caring for participants may not be the ideal 198	
recruiters of individuals onto a study. As an additional limitation in our study, we had a reduced 199	
number of participants within the underweight and obese categories, although this was due to the 200	
nature of the sampling.  201	
 202	
The strengths of our study are the use of probability sampling in the selection of the study population. 203	
In addition, we were able to draw a valid sample size representative of the total population of 204	
expectant mothers in our setting. Unlike other studies, our sample was categorised by pre-gestational 205	
maternal BMI, an important independent factor in determining birth weight.  206	
 207	
Different studies have tried to determine the relationship between cigarette smoking among expectant 208	
mothers and birth weight. Although the studies have produced heterogeneous results, most observe an 209	
increased risk of lower birth weight among smokers1,19-21. However, the studies are limited by the 210	
difficulty in quantifying maternal exposure precisely and in adjusting for the multiplicity of 211	
confounding factors that can affect birth weight32,33. 212	
 213	
In conclusion, our results on the association of active smoking during pregnancy with birth weight 214	
indicate that smoking in pregnancy increased the risk of having lower weight newborns (<3000g), and 215	
that this risk is most pronounced for women who smoke during their third trimester, reinforcing the 216	
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need to encourage and support women to avoid smoking during pregnancy. Pregnancy offers a 217	
strategic opportunity for health professionals to promote smoking cessation and motivate women to 218	
give up tobacco use. Such opportunity to encourage smoking cessation interventions should be 219	
specially seized by midwives, as first point of contact for women during their pregnancy.  220	
ACKNOWLEDGEMENTS AND DISCLOSURES 221	
The authors would like to thank all study participants. We also acknowledge the managers of the 222	
University Hospital of La Ribera for their support during our research. We would like to thank 223	
Meggan Harris, Professor of Preventive Medicine and Public Health at Universitat de València 224	
(Spain) for the translation of this paper and feedback. The authors have no conflicts of interest to 225	
disclose. 226	
227	
	 10	
REFERENCES 228	
1.	 Mercer	BM,	Merlino	AA,	Milluzzi	 CJ,	Moore	 JJ.	 Small	 fetal	 size	 before	 20	weeks'	229	 gestation:	 associations	 with	 maternal	 tobacco	 use,	 early	 preterm	 birth,	 and	 low	230	 birthweight.	Am	J	Obstet	Gynecol	2008;	198(6):	673	e1-7;	discussion		e7-8.	231	 2.	 Simas	 TA,	 Liao	 X,	 Garrison	 A,	 Sullivan	 GM,	 Howard	 AE,	 Hardy	 JR.	 Impact	 of	232	 updated	 Institute	 of	 Medicine	 guidelines	 on	 prepregnancy	 body	 mass	 index	233	 categorization,	 gestational	 weight	 gain	 recommendations,	 and	 needed	 counseling.	 J	234	
Womens	Health	(Larchmt)	2011;	20(6):	837-44.	235	 3.	 Nohr	 EA,	 Vaeth	 M,	 Baker	 JL,	 Sorensen	 TI,	 Olsen	 J,	 Rasmussen	 KM.	 Pregnancy	236	 outcomes	related	to	gestational	weight	gain	in	women	defined	by	their	body	mass	index,	237	 parity,	height,	and	smoking	status.	Am	J	Clin	Nutr	2009;	90(5):	1288-94.	238	 4.	 Jaddoe	VW,	Troe	EJ,	Hofman	A,	et	al.	Active	and	passive	maternal	smoking	during	239	 pregnancy	and	the	risks	of	low	birthweight	and	preterm	birth:	the	Generation	R	Study.	240	
Paediatr	Perinat	Epidemiol	2008;	22(2):	162-71.	241	 5.	 Geelhoed	JJ,	El	Marroun	H,	Verburg	BO,	et	al.	Maternal	smoking	during	pregnancy,	242	 fetal	 arterial	 resistance	 adaptations	 and	 cardiovascular	 function	 in	 childhood.	 BJOG	243	 2011;	118(6):	755-62.	244	 6.		 Mateos-Vilchez	PM,	Aranda-Regules	JM,	Diaz-Alonso	G,	et	al.	[Smoking	prevalence	245	 and	associated	factors	during	pregnancy	in	Andalucia	2007-2012].	Rev	Esp	Salud	Publica	246	 2014;	88(3):	369-81.	247	 7.	 Russell	 T,	 Crawford	 M,	 Woodby	 L.	 Measurements	 for	 active	 cigarette	 smoke	248	 exposure	in	prevalence	and	cessation	studies:	why	simply	asking	pregnant	women	isn't	249	 enough.	Nicotine	Tob	Res	2004;	6	Suppl	2:	S141-51.	250	 8.		 Peacock	 JL,	 Cook	DG,	 Carey	 IM,	 et	 al.	Maternal	 cotinine	 level	 during	 pregnancy	251	 and	birthweight	for	gestational	age.	Int	J	Epidemiol	1998;	27(4):	647-56.	 	252	 9.	 Vardavas	CI,	Patelarou	E,	Chatzi	L,	et	al.	Factors	associated	with	active	smoking,	253	 quitting,	 and	 secondhand	 smoke	 exposure	 among	 pregnant	 women	 in	 Greece.	 J	254	
Epidemiol	2010;	20(5):	355-62.	255	 10.	 Salvador	 J,	 Villalbi	 JR,	 Nebot	 M,	 Borrell	 C.	 [Exposure	 to	 smoking	 during	256	 pregnancy:	Barcelona	(Spain)	1994-2001].	An	Pediatr	(Barc)	2004;	60(2):	139-41.	257	 11.	 Jimenez-Muro	 A,	 Samper	MP,	Marqueta	 A,	 Rodriguez	 G,	 Nerin	 I.	 [Prevalence	 of	258	 smoking	and	second-hand	smoke	exposure:	differences	between	Spanish	and	immigrant	259	 pregnant	women].	Gac	Sanit	2012;	26(2):	138-44.	260	 12.	 Goetzinger	 KR,	 Cahill	 AG,	 Macones	 GA,	 Odibo	 AO.	 The	 relationship	 between	261	 maternal	 body	mass	 index	 and	 tobacco	 use	 on	 small-for-gestational-age	 infants.	Am	 J	262	
Perinatol	2012;	29(3):	153-8.	263	 13.	 Iniguez	C,	Ballester	F,	Costa	O,	et	al.	Maternal	smoking	during	pregnancy	and	fetal	264	 biometry:	the	INMA	Mother	and	Child	Cohort	Study.	Am	J	Epidemiol	2013;	178(7):	1067-265	 75.	266	 14.	 Iniguez	 C,	 Ballester	 F,	 Amoros	 R,	 Murcia	 M,	 Plana	 A,	 Rebagliato	 M.	 Active	 and	267	 passive	smoking	during	pregnancy	and	ultrasound	measures	of	fetal	growth	in	a	cohort	268	 of	pregnant	women.	J	Epidemiol	Community	Health	2012;	66(6):	563-70.	269	 15.	 England	LJ,	Kendrick	JS,	Wilson	HG,	Merritt	RK,	Gargiullo	PM,	Zahniser	SC.	Effects	270	 of	 smoking	 reduction	 during	 pregnancy	 on	 the	 birth	 weight	 of	 term	 infants.	 Am	 J	271	
Epidemiol	2001;	154(8):	694-701.	272	 16.	 Bernstein	 IM,	Mongeon	 JA,	Badger	GJ,	 Solomon	L,	Heil	 SH,	Higgins	ST.	Maternal	273	 smoking	and	its	association	with	birth	weight.	Obstet	Gynecol	2005;	106(5	Pt	1):	986-91.	274	
	 11	
17.	 Andersen	CS,	Gamborg	M,	TI	SXfR,	Nohr	EA.	Weight	gain	 in	different	periods	of	275	 pregnancy	 and	 offspring's	 body	mass	 index	 at	 7	 years	of	 age.	 Int	 J	Pediatr	Obes	 2010;	276	
6(2-2):	e179-86.	277	 18.	 Stein	AD,	Zybert	PA,	van	de	Bor	M,	Lumey	LH.	Intrauterine	famine	exposure	and	278	 body	proportions	at	birth:	the	Dutch	Hunger	Winter.	Int	J	Epidemiol	2004;	33(4):	831-6.	279	 19.	 Kharrazi	M,	DeLorenze	GN,	Kaufman	FL,	et	al.	Environmental	tobacco	smoke	and	280	 pregnancy	outcome.	Epidemiology	2004;	15(6):	660-70.	281	 20.	 Cano-Serral	 G,	 Rodriguez-Sanz	 M,	 Borrell	 C,	 Perez	 Mdel	 M,	 Salvador	 J.	282	 [Socioeconomic	 inequalities	 in	 the	 provision	 and	 uptake	 of	 prenatal	 care].	 Gac	 Sanit	283	 2006;	20(1):	25-30.	284	 21.	 Ribot	 B,	 Isern	R,	Hernandez-Martinez	 C,	 Canals	 J,	 Aranda	N,	 Arija	 V.	 [Effects	 of	285	 tobacco	 habit,	 second-hand	 smoking	 and	 smoking	 cessation	 during	 pregnancy	 on	286	 newborn's	health].	Med	Clin	(Barc)	2014;	143(2):	57-63.	287	 22.	 Britton	GR,	James	GD,	Collier	R,	Sprague	LM,	Brinthaupt	J.	The	effects	of	smoking	288	 cessation	and	a	programme	intervention	on	birth	and	other	perinatal	outcomes	among	289	 rural	pregnant	smokers.	Ann	Hum	Biol	2013;	40(3):	256-65.	290	 23.	 Mathai	 M,	 Skinner	 A,	 Lawton	 K,	 Weindling	 AM.	 Maternal	 smoking,	 urinary	291	 cotinine	levels	and	birth-weight.	Aust	N	Z	J	Obstet	Gynaecol	1990;	30(1):	33-6.	292	 24.	 Anderka	 M,	 Romitti	 PA,	 Sun	 L,	 et	 al.	 Patterns	 of	 tobacco	 exposure	 before	 and	293	 during	pregnancy.	Acta	Obstet	Gynecol	Scand	2010;	89(4):	505-14.	294	 25.	 Samper	 MP,	 Jimenez-Muro	 A,	 Nerin	 I,	 Marqueta	 A,	 Ventura	 P,	 Rodriguez	 G.	295	 Maternal	 active	 smoking	and	newborn	body	composition.	Early	Hum	Dev	 2012;	88(3):	296	 141-5.	297	 26.	 Florescu	 A,	 Ferrence	 R,	 Einarson	 T,	 Selby	 P,	 Soldin	 O,	 Koren	 G.	 Methods	 for	298	 quantification	 of	 exposure	 to	 cigarette	 smoking	 and	 environmental	 tobacco	 smoke:	299	 focus	on	developmental	toxicology.	Therapeutic	drug	monitoring	2009;	31(1):	14-30.	300	 27.	 Patrick	DL,	Cheadle	A,	Thompson	DC,	Diehr	P,	Koepsell	T,	Kinne	S.	The	validity	of	301	 self-reported	 smoking:	 a	 review	 and	 meta-analysis.	 Am	 J	 Public	 Health	 1994;	 84(7):	302	 1086-93.	303	 28.	 Almeida	 ND,	 Koren	 G,	 Platt	 RW,	 Kramer	 MS.	 Hair	 biomarkers	 as	 measures	 of	304	 maternal	tobacco	smoke	exposure	and	predictors	of	fetal	growth.	Nicotine	Tob	Res	2011;	305	
13(5):	328-35.	306	 29.	 Spanier	AJ,	Kahn	RS,	Xu	Y,	Hornung	R,	Lanphear	BP.	Comparison	of	biomarkers	307	 and	parent	report	of	tobacco	exposure	to	predict	wheeze.	J	Pediatr	2011;	159(5):	776-308	 82.	309	 30.	 Hoekzema	L,	Werumeus	Buning	A,	Bonevski	B,	et	al.	Smoking	rates	and	smoking	310	 cessation	 preferences	 of	 pregnant	 women	 attending	 antenatal	 clinics	 of	 two	 large	311	 Australian	maternity	hospitals.	Aust	N	Z	J	Obstet	Gynaecol	2014;	54(1):	53-8.	312	 31.	 Myers	RE.	Promoting	healthy	behaviors:	How	do	we	get	the	message	across?	Int	J	313	
Nurs	Stud	2010;	47(4):	500-12.	314	 32.	 Mendelsohn	C,	Gould	GS,	Oncken	C.	Management	of	smoking	in	pregnant	women.	315	
Aust	Fam	Physician	2014;	43(1):	46-51.	316	 33.	 Ino	T.	Maternal	smoking	during	pregnancy	and	offspring	obesity:	meta-analysis.	317	
Pediatr	Int	2010;	52(1):	94-9.	318	
 319	
